GRINM Semiconductor Materials Co., Ltd. (SHA:688432)

Market Cap	14.34B
Revenue (ttm)	992.09M
Net Income (ttm)	225.60M
Shares Out	1.24B
EPS (ttm)	0.18
PE Ratio	63.69
Forward PE	52.41
Dividend	0.07 (0.61%)
Ex-Dividend Date	Jun 25, 2025

Volume	5,272,405
Average Volume	5,576,231
Open	11.50
Previous Close	11.51
Day's Range	11.45 - 11.61
52-Week Range	8.30 - 14.50
Beta	0.97
RSI	57.25
Earnings Date	Aug 14, 2025

About Blueprint Medicines

GRINM Semiconductor Materials Co., Ltd. engages in the research, development, production, and operation of silicon and other semiconductor materials and equipment in China. The company offers large-diameter silicon single crystals and products, such as silicon rods, rings, and slices; zone-melted silicon single crystals; and heavily doped, lightly doped, and zone fused wafers, as well as corrosion sheets. It also provides related technology development, technology transfer and technical consulting services. In addition, the company exports its ...

• Industry: Semiconductor Equipment & Materials
• Sector: Technology
• Founded: 2001
• Employees: 772
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688432

Financial Performance

In 2024, SHA:688432's revenue was 995.95 million, an increase of 3.70% compared to the previous year's 960.40 million. Earnings were 232.90 million, a decrease of -8.37%.